Literature DB >> 7417931

On the nature of susceptibility to cancer. The presidential address.

D G Miller.   

Abstract

The most prominent factor determining susceptibility to cancer is age. However, there is little evidence that the aging process per se increases susceptibility to cancer. Rather, age provides the time necessary for the accumulation of cellular events required for the development of neoplasia. The variations in the patterns of cancer incidence rates seen with age can be explained by alterations in conditions of exposure to carcinogenic stimuli. There is no evidence that the pool of susceptible individuals in a population is limited. Cancer occurs as a random event in a population with greater or lesser frequency according to the presence of risk factors. In populations with an increased frequency of cancer such as those with genetic abnormalities, immune deficiency syndromes, or altered hormonal states, the risk of developing cancer is never generalized to all tissues but is characteristic of particular tissues at risk. Any circumstance of internal or external origin that disturbs homeostasis of particular tissues at risk. Any circumstance of internal or external origin that disturbs homeostasis over a prolonged period of time increases the susceptibility to cancer for the tissue concerned. Susceptibility to cancer does not mean that cancer is inevitable. Only a small number of those susceptible to cancer by virtue of a special risk factor develop the disease. Furthermore, most patients who develop cancer have no determinable risk factors. Although all evidence points to a multifactorial, multistage process, the rate of somatic mutation appears to be the key determinant factor in susceptibility to cancer. This concept is supported by research studies showing that the onset of atherosclerosis is initiated by somatic mutations, and the finding that the same chemical mutagens can advance the development of both diseases.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7417931     DOI: 10.1002/1097-0142(19800915)46:6<1307::aid-cncr2820460602>3.0.co;2-6

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  16 in total

1.  Mortality from prostate cancer in Italy: 1950-1979. Cross-sectional rates and cohort analysis.

Authors:  F La Rosa; A Cresci; C Orpianesi; G Saltalamacchia
Journal:  Eur J Epidemiol       Date:  1985-06       Impact factor: 8.082

2.  Histopathologic variants of basal cell carcinoma correlation with sex, age and localization.

Authors:  N Puizina-Ivić; B Matoković; I Gluncić; S Maslovara; J Vela-Ljubić
Journal:  J Med Syst       Date:  1999-10       Impact factor: 4.460

Review 3.  Depressed immunity and the development of cancer.

Authors:  I Penn
Journal:  Clin Exp Immunol       Date:  1981-12       Impact factor: 4.330

4.  DrGaP: a powerful tool for identifying driver genes and pathways in cancer sequencing studies.

Authors:  Xing Hua; Haiming Xu; Yaning Yang; Jun Zhu; Pengyuan Liu; Yan Lu
Journal:  Am J Hum Genet       Date:  2013-08-15       Impact factor: 11.025

5.  Molecular changes consistent with increased proliferation and invasion are common in rectal cancer.

Authors:  R Hughes; J Parry; J Beynon; G Jenkins
Journal:  Clin Transl Oncol       Date:  2011-10       Impact factor: 3.405

Review 6.  Brain tumor stem cells as therapeutic targets in models of glioma.

Authors:  Dan Richard Laks; Koppany Visnyei; Harley Ian Kornblum
Journal:  Yonsei Med J       Date:  2010-09       Impact factor: 2.759

Review 7.  Genomic and Epigenomic Alterations in Cancer.

Authors:  Balabhadrapatruni V S K Chakravarthi; Saroj Nepal; Sooryanarayana Varambally
Journal:  Am J Pathol       Date:  2016-07       Impact factor: 4.307

Review 8.  The cancer genome.

Authors:  Michael R Stratton; Peter J Campbell; P Andrew Futreal
Journal:  Nature       Date:  2009-04-09       Impact factor: 49.962

9.  The landscape of cancer genes and mutational processes in breast cancer.

Authors:  Philip J Stephens; Patrick S Tarpey; Helen Davies; Peter Van Loo; Chris Greenman; David C Wedge; Serena Nik-Zainal; Sancha Martin; Ignacio Varela; Graham R Bignell; Lucy R Yates; Elli Papaemmanuil; David Beare; Adam Butler; Angela Cheverton; John Gamble; Jonathan Hinton; Mingming Jia; Alagu Jayakumar; David Jones; Calli Latimer; King Wai Lau; Stuart McLaren; David J McBride; Andrew Menzies; Laura Mudie; Keiran Raine; Roland Rad; Michael Spencer Chapman; Jon Teague; Douglas Easton; Anita Langerød; Ming Ta Michael Lee; Chen-Yang Shen; Benita Tan Kiat Tee; Bernice Wong Huimin; Annegien Broeks; Ana Cristina Vargas; Gulisa Turashvili; John Martens; Aquila Fatima; Penelope Miron; Suet-Feung Chin; Gilles Thomas; Sandrine Boyault; Odette Mariani; Sunil R Lakhani; Marc van de Vijver; Laura van 't Veer; John Foekens; Christine Desmedt; Christos Sotiriou; Andrew Tutt; Carlos Caldas; Jorge S Reis-Filho; Samuel A J R Aparicio; Anne Vincent Salomon; Anne-Lise Børresen-Dale; Andrea L Richardson; Peter J Campbell; P Andrew Futreal; Michael R Stratton
Journal:  Nature       Date:  2012-05-16       Impact factor: 49.962

10.  Insertional mutagenesis identifies multiple networks of cooperating genes driving intestinal tumorigenesis.

Authors:  H Nikki March; Alistair G Rust; Nicholas A Wright; Jelle ten Hoeve; Jeroen de Ridder; Matthew Eldridge; Louise van der Weyden; Anton Berns; Jules Gadiot; Anthony Uren; Richard Kemp; Mark J Arends; Lodewyk F A Wessels; Douglas J Winton; David J Adams
Journal:  Nat Genet       Date:  2011-11-06       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.